Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis

[1] Saito Y(2011)Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis Ann Thorac Surg 92 1812-1817

[2] Kawai Y(2008)Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg 136 1357-1363

[3] Takahashi N(2000)Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study Am J Respir Crit Care Med 161 5-8

[4] Ikeya T(2005)Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 171 1040-1047

[5] Murai K(2014)A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis N Engl J Med. 370 2083-2092

[6] Kawabata Y(2007)Acute exacerbations of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 176 636-643

[7] Watanabe A(2006)Histological changes are background factors in acute exacerbation of usual interstitial pneumonia pattern/lesions following lung resection (in Japanese with English abstract) Haigan (Jpn J Lung Cancer). 46 329-336

[8] Higami T(2009)Histological characteristics in the prediction of acute exacerbation of idiopathic pulmonary fibrosis (IPF) following surgery for primary lung cancer Mod Pathol 22 358A-824

[9] Ohori S(2011)An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 788-137

[10] Koyanagi T(2010)Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study Chest. 137 129-76

[1] Saito Y(2011)Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis Ann Thorac Surg 92 1812-1817

[2] Kawai Y(2008)Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg 136 1357-1363

[3] Takahashi N(2000)Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study Am J Respir Crit Care Med 161 5-8

[4] Ikeya T(2005)Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 171 1040-1047

[5] Murai K(2014)A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis N Engl J Med. 370 2083-2092

[6] Kawabata Y(2007)Acute exacerbations of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 176 636-643

[7] Watanabe A(2006)Histological changes are background factors in acute exacerbation of usual interstitial pneumonia pattern/lesions following lung resection (in Japanese with English abstract) Haigan (Jpn J Lung Cancer). 46 329-336

[8] Higami T(2009)Histological characteristics in the prediction of acute exacerbation of idiopathic pulmonary fibrosis (IPF) following surgery for primary lung cancer Mod Pathol 22 358A-824

[9] Ohori S(2011)An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 788-137

[10] Koyanagi T(2010)Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study Chest. 137 129-76